Sumitomo Mitsui Ds Asset Management Company, LTD Biomarin Pharmaceutical Inc Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

$9.15 Billion
Q3 2024

A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 20,763 shares of BMRN stock, worth $1.41 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

20,763

Previous 16,824 23.41%

Holding current value

$1.41 Million

Previous $1.39 Million 5.34%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$69.02 - $93.84 $271,869 - $369,635	3,939 Added 23.41%	20,763 $1.46 Million
Q2 2024 Jul 30, 2024	BUY	$74.43 - $92.22 $8,708 - $10,789	117 Added 0.7%	16,824 $1.39 Million
Q1 2024 May 02, 2024	SELL	$83.81 - $99.0 $4,525 - $5,346	-54 Reduced 0.32%	16,707 $1.46 Million
Q4 2023 Feb 01, 2024	BUY	$76.22 - $98.51 $5,564 - $7,191	73 Added 0.44%	16,761 $1.62 Million
Q3 2023 Oct 30, 2023	SELL	$85.07 - $94.48 $3,487 - $3,873	-41 Reduced 0.25%	16,688 $1.48 Million
Q2 2023 Aug 04, 2023	SELL	$86.68 - $100.3 $1,646 - $1,905	-19 Reduced 0.11%	16,729 $1.45 Million
Q1 2023 May 02, 2023	BUY	$87.74 - $117.27 $199,608 - $266,789	2,275 Added 15.72%	16,748 $1.63 Million
Q3 2022 Oct 19, 2022	BUY	$82.16 - $96.94 $9,612 - $11,341	117 Added 0.81%	14,473 $1.23 Million
Q2 2022 Jul 13, 2022	BUY	$71.48 - $86.85 $184,704 - $224,420	2,584 Added 21.95%	14,356 $1.19 Million
Q1 2022 Apr 19, 2022	SELL	$74.28 - $92.69 $7,353 - $9,176	-99 Reduced 0.83%	11,772 $908,000
Q4 2021 Jan 20, 2022	BUY	$71.72 - $91.47 $159,074 - $202,880	2,218 Added 22.98%	11,871 $1.05 Million
Q3 2021 Oct 15, 2021	SELL	$74.77 - $85.47 $4,860 - $5,555	-65 Reduced 0.67%	9,653 $746,000
Q3 2020 Oct 29, 2020	SELL	$71.87 - $131.03 $3,234 - $5,896	-45 Reduced 0.46%	9,718 $739,000
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $1,193 - $1,863	15 Added 0.15%	9,763 $1.2 Million
Q1 2020 Apr 21, 2020	BUY	$71.37 - $96.85 $4,995 - $6,779	70 Added 0.72%	9,748 $823,000
Q3 2019 Oct 16, 2019	BUY	$67.4 - $85.11 $105,413 - $133,112	1,564 Added 19.28%	9,678 $652,000
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $215,337 - $251,652	-2,680 Reduced 24.83%	8,114 $694,000
Q1 2019 May 07, 2019	BUY	$84.2 - $98.62 $926 - $1,084	11 Added 0.1%	10,794 $958,000
Q4 2018 Jan 25, 2019	BUY	$80.14 - $106.07 $16,428 - $21,744	205 Added 1.94%	10,783 $918,000
Q3 2018 Oct 15, 2018	SELL	$93.92 - $105.72 $25,640 - $28,861	-273 Reduced 2.52%	10,578 $1.03 Million
Q1 2018 Apr 25, 2018	SELL	$77.67 - $92.63 $88,000 - $104,949	-1,133 Reduced 9.45%	10,851 $879,000
Q4 2017 Jan 25, 2018	SELL	$80.76 - $95.13 $20,190 - $23,782	-250 Reduced 2.04%	11,984 $1.07 Million
Q3 2017 Oct 27, 2017	BUY	$80.6 - $94.95 $986,060 - $1.16 Million	12,234	12,234 $1.14 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.6B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Account

Sumitomo Mitsui Ds Asset Management Company, LTD Biomarin Pharmaceutical Inc Transaction History